1. Home
  2. KNF vs PTCT Comparison

KNF vs PTCT Comparison

Compare KNF & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Knife Riv Holding Co.

KNF

Knife Riv Holding Co.

HOLD

Current Price

$87.77

Market Cap

5.0B

Sector

N/A

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$64.50

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KNF
PTCT
Founded
1917
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.5B
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
KNF
PTCT
Price
$87.77
$64.50
Analyst Decision
Buy
Buy
Analyst Count
8
17
Target Price
$96.50
$79.41
AVG Volume (30 Days)
577.6K
1.0M
Earning Date
01-01-0001
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
264.48
EPS
2.76
7.78
Revenue
$3,146,012,000.00
$264,734,000.00
Revenue This Year
$6.17
N/A
Revenue Next Year
$4.37
$22.81
P/E Ratio
$32.07
$8.58
Revenue Growth
8.52
36.19
52 Week Low
$58.72
$35.95
52 Week High
$101.02
$87.50

Technical Indicators

Market Signals
Indicator
KNF
PTCT
Relative Strength Index (RSI) 60.15 25.11
Support Level $76.66 $57.74
Resistance Level $94.23 $68.44
Average True Range (ATR) 3.57 2.85
MACD 0.10 -0.42
Stochastic Oscillator 58.57 10.94

Price Performance

Historical Comparison
KNF
PTCT

About KNF Knife Riv Holding Co.

Knife River Holding Co is an aggregates-led construction materials and contracting services provider. The segments of the company include West, Mountain, Central, and Energy Services. Each geographic segment offers a vertically integrated suite of products and services, including aggregates, ready-mix concrete, asphalt, and contracting services, while the Energy Services segment, which has locations throughout the company's geographic footprint, produces and supplies liquid asphalt and related services, for use in asphalt road construction, and is a supplier to some of the other segments.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: